MedPath
HSA Approval

MST CONTINUS TABLET 30 mg

SIN05508P

MST CONTINUS TABLET 30 mg

MST CONTINUS TABLET 30 mg

March 4, 1991

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Licence HolderMUNDIPHARMA PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N02AA01

morphine

Manufacturer Information

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

BARD PHARMACEUTICALS LTD

Active Ingredients

MORPHINE SULPHATE

30 mg

Morphine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MST CONTINUS TABLET 30 mg - HSA Approval | MedPath